Senseonics price target raised to $1.40 from $1.10 at H.C. Wainwright

H.C. Wainwright raised the firm’s price target on Senseonics (SENS) to $1.40 from $1.10 and keeps a Buy rating on the shares following the company’s analyst event. Senseonics presented plans to increase the number of Eversense patients from approximately 13,000 in 2025 to over 50,000 by 2027, the analyst tells investors in a research note. The firm says management believes the company could reach operational break even by the end of 2027.